投融资数据库
免费查数据
注册送3天会员
首页>投融资
Sherlock Biosciences
收并购
Sherlock Biosciences Inc operates as an engineering biology company. The Company develops a molecular diagnostics platform.In February 2023, Sense Biodetection Ltd was acquired by Sherlock Biosciences Inc.In June 2021, Sherlock Biosciences had Partnered with NorDx Laboratories.In March 2022, Sherlock Biosciences Inc announced it has raised $80 million in a Series B financing
基本信息
-
公司全称Sherlock Biosciences Inc
-
类型分子诊断产品开发商
-
产业领域医疗器械
-
公司人数15~50人
-
地址40 Guest Street 3Rd Floor BRIGHTON MASSACHUSETTS 02135; US; Telephone: +16176128209;
-
联系电话
-
邮箱partners@sherlock.bio
-
成立时间2019-02-01
投融资
-
2024-12-19
-
2022-03-08
-
2019-04-23
-
2019-03-22
- 加载更多
相关投融资企业
D轮
ViCentra BV develops, manufactures and markets next generation insulin pumps and other products to treat people with diabetes.In December 2021, ViCentra BV announced the closing of a EUR 65 million (USD 74 million) Series C financing
C轮
Inquis Medical是一家专注于外周血管创新的临床阶段医疗器械公司，开发一种外周血栓切除医疗设备，旨在解决未满足的临床需求并提高护理标准。该公司的技术专注于改善静脉血栓栓塞性疾病的管理，并提供有效的单次血栓切除术，减少出血量，使客户能够拥有具有长期影响的医疗设备，以满足未满足的需求。
收并购
Vivasure Medical is a medical device company and developer of absorbable, patch-based closure devices specifically designed to seal large-bore arteriotomies in endovascular procedures.In May 2022, Vivasure Medical closed the first tranche of €22 million as part of its Series D financing round that could reach up to €52 million in total and was led by a multi-national strategic corporation
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息